# Safe and Efficacious Artemisinin-based Combination Treatments for African Pregnant Women With Malaria

> **NCT00852423** · PHASE3 · COMPLETED · sponsor: **Institute of Tropical Medicine, Belgium** · enrollment: 3428 (actual)

## Conditions studied

- Malaria in Pregnancy

## Interventions

- **DRUG:** Dihydroartemisinin-piperaquine
- **DRUG:** Artesunate-mefloquine
- **DRUG:** Artesunate-amodiaquine
- **DRUG:** Artemether-lumefantrine

## Key facts

- **NCT ID:** NCT00852423
- **Lead sponsor:** Institute of Tropical Medicine, Belgium
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2013-10
- **Final completion:** 2015-04
- **Target enrollment:** 3428 (ACTUAL)
- **Last updated:** 2016-03-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00852423

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00852423, "Safe and Efficacious Artemisinin-based Combination Treatments for African Pregnant Women With Malaria". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00852423. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*